About Us
Flourish Research is where clinical trials thrive.
Explore Flourish Research – Miami (Kendall)
Our History
Flourish Miami (Kendall) started out as Clinical Trials of Florida. It conducted Respiratory and Sleep trials, later expanding into Phase I-IV Neuroscience and Infectious Diseases studies. Flourish Miami (Kendall) has also served as the central lab for complex Spirometry testing. The site is led by Dr. Mark Rosenthal, a Family Practice physician board-certified in Sleep Medicine. The site joined Clinical Site Partners, founded by Dr. Faisal A. Fakih and Ana T. Marquez. The team pride themselves on their patient diversity, high retention rate, and proven quality data.
Championing Inclusivity In Your Research Journey
At Flourish Research, we strive toward excellence. In clinical trials and healthcare, excellence means everyone deserves the best care, regardless of their race, color, gender identity, religion, ethnicity, physical abilities, age, sexual orientation, or veteran status. We embrace employees, customers, and patients from all underrepresented groups to help make this vision a reality.
Flourish Research is driven by a diverse and inclusive community of passionate people who are committed to improving the quality of life of communities around the world. Flourish is committed to a safe work environment where all employees, customers, and patients are included, and treated with dignity and respect.
Flourish strives to build an organization that attracts and leverages diversity in our staff, which reflects the diversity of our local communities. We promote education, acceptance, and inclusion because there is beauty in diversity. The more diversity we have in our team, the more unique perspectives, and ideas we share, and the better prepared we are to serve our communities. WE SEE YOU. WE ARE YOU. WE EMBRACE YOU. WE CELEBRATE YOU!
Participant Stories
Flourish Research News
Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.